Another DCLK1-targeted mAb, DCLK1-87, stains tissue regions with CSC-marker ALDH expression in CRC, and CRC patients bearing tumors with low tissue staining intensity from this mAb showed improved survival [83]. This evidence concerns the gene LDHA and colorectal carcinoma.